Skadden represented Actavis PLC and Watson Laboratories (Actavis) in securing the dismissal of antitrust claims filed by direct purchaser plaintiffs alleging a scheme to delay generic competition for the diabetes drug Actos. Judge Ronnie Abrams of the U.S. District Court for the Southern District of New York dismissed all claims against Actavis on October 8.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates